These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9064053)

  • 1. [Tumor necrosis factor and induced labor].
    Rongières-Bertrand C; Menu E; Lelaidier C; Delage G; Chaouat G; Frydman R
    Contracept Fertil Sex; 1997 Jan; 25(1):51-7. PubMed ID: 9064053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
    Väyrynen W; Heikinheimo O; Nuutila M
    Acta Obstet Gynecol Scand; 2007; 86(6):701-5. PubMed ID: 17520402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of induction of labour regimes for termination of pregnancy, with and without mifepristone, from 20 to 41 weeks gestation.
    Fyfe R; Murray H
    Aust N Z J Obstet Gynaecol; 2017 Dec; 57(6):604-608. PubMed ID: 28580577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of pregnancy with mifepristone after intra-uterine death. Clinical and hormonal effects.
    Padayachi T; Moodley J; Norman RJ; Heyns A
    S Afr Med J; 1989 Jun; 75(11):540-2. PubMed ID: 2658142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of mifepristone to ripen the cervix and induce labor in term pregnancies.
    Berkane N; Verstraete L; Uzan S; Boog G; Maria B
    Am J Obstet Gynecol; 2005 Jan; 192(1):114-20. PubMed ID: 15672012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of oral mifepristone to intravenous oxytocin for labor induction in women with prelabor rupture of membranes beyond 36 weeks' gestation.
    Wing DA; Guberman C; Fassett M
    Am J Obstet Gynecol; 2005 Feb; 192(2):445-51. PubMed ID: 15695985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of labor with mifepristone--a randomized, double-blind study versus placebo.
    Stenlund PM; Ekman G; Aedo AR; Bygdeman M
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):793-8. PubMed ID: 10535343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mifepristone--a new antiprogesterone in obstetrics and gynecology].
    Aschkenazi S; Levy T; Ben-Rafael Z
    Harefuah; 2001 May; 140(5):429-34. PubMed ID: 11419069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of fetal umbilical artery flow velocity during induction of term labor by mifepristone].
    Jiang X; Wang H; Zhang Z
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):732-4. PubMed ID: 9772437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mifepristone for induction of labor].
    Su H; Li E; Weng L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):676-80. PubMed ID: 9387530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks' gestation.
    Fassett MJ; Wing DA
    Gynecol Obstet Invest; 2008; 65(2):112-5. PubMed ID: 17912003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind, randomized trial on augmentation of labour with a combination of intravenous propranolol and oxytocin versus oxytocin only.
    Palomäki O; Uotila J; Tammela O; Kaila T; Lavapuro M; Huhtala H; Tuimala R
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):44-9. PubMed ID: 16051416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Labor induction in women at term with mifepristone and it's safety].
    Zhang N; Hu Y
    Zhonghua Fu Chan Ke Za Zhi; 1999 Dec; 34(12):751-3. PubMed ID: 11479963
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of mifepristone on the expression of tumor necrosis factor-alpha and transforming growth factor-beta in decidua of early pregnancy].
    Zhang J; Xia E; Zhang J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):27-9. PubMed ID: 11778540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of early pregnancy with mifepristone in combination with gemeprost.
    Sandstrøm O; Brooks L; Schantz A; Grinsted J; Grinsted L; Jacobsen JD; Nielsen SP
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):806-9. PubMed ID: 10535346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of labour: which method to use?].
    Tinelli A; Tinelli R; Tinelli FG
    Minerva Ginecol; 2003 Dec; 55(6):463-82. PubMed ID: 14676736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiprogestin to clinical use].
    Heikinheimo O
    Duodecim; 2000; 116(12):1261-2. PubMed ID: 11988960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early termination of pregnancy with pharmacological means].
    Honkanen H; von Hertzen H
    Duodecim; 2000; 116(12):1277-82; quiz 1283, 1308. PubMed ID: 11988962
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical applications of mifepristone.
    Tang OS; Ho PC
    Gynecol Endocrinol; 2006 Dec; 22(12):655-9. PubMed ID: 17162706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.